Apabetalone ( DrugBank: Apabetalone )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	2

86. Pulmonary arterial hypertension

---

Clinical trials : 1,181 /  Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04915300 (ClinicalTrials.gov)	March 2022	19/5/2021	Apabetalone for Pulmonary Arterial Hypertension	Apabetalone for Pulmonary Arterial Hypertension: a Phase 2 Clinical Study	Pulmonary Arterial Hypertension	Drug: Apabetalone;Drug: Placebo	Laval University	Canadian Institutes of Health Research (CIHR);Resverlogix Corp	Not yet recruiting	18 Years	75 Years	All	72	Phase 2	Canada
2	NCT03655704 (ClinicalTrials.gov)	August 22, 2019	28/8/2018	Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study	Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study	Pulmonary Arterial Hypertension	Drug: Apabetalone	Steeve Provencher	Resverlogix Corp	Active, not recruiting	18 Years	75 Years	All	7	Early Phase 1	Canada